Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suppression of Inflammation by Using NSAIDs During Peri-operative Period Can Affect the Prognosis of Breast Cancer.

NCT02141139 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02141139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02141139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suppression of Inflammation by Using NSAIDs During Peri-operative Period Can Affect the Prognosis of Breast Cancer.
Lead sponsor
Samsung Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2014
Completion date
Not reported
Enrollment
1,568 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms